Quantification of Left Atrial Fibrosis in Patients After Pulmonary Vein Isolation Using the Second-Generation Cryoballoon
Standard
Quantification of Left Atrial Fibrosis in Patients After Pulmonary Vein Isolation Using the Second-Generation Cryoballoon. / Rottner, Laura; Heeger, Christian-Hendrik; Lemes, Christine; Wohlmuth, Peter; Maurer, Tilman; Reissmann, Bruno; Fink, Thomas; Mathew, Shibu; Ouyang, Feifan; Kuck, Karl-Heinz; Metzner, Andreas; Rillig, Andreas.
In: INT HEART J, Vol. 62, No. 1, 30.01.2021, p. 65-71.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Quantification of Left Atrial Fibrosis in Patients After Pulmonary Vein Isolation Using the Second-Generation Cryoballoon
AU - Rottner, Laura
AU - Heeger, Christian-Hendrik
AU - Lemes, Christine
AU - Wohlmuth, Peter
AU - Maurer, Tilman
AU - Reissmann, Bruno
AU - Fink, Thomas
AU - Mathew, Shibu
AU - Ouyang, Feifan
AU - Kuck, Karl-Heinz
AU - Metzner, Andreas
AU - Rillig, Andreas
PY - 2021/1/30
Y1 - 2021/1/30
N2 - Left atrial (LA) fibrosis is associated with a poor outcome after atrial fibrillation (AF) ablation. This study examined the extent of low-voltage areas in patients with recurrence of atrial tachyarrhythmia (ATA) after CB-based pulmonary vein isolation (PVI).Sixty patients (mean age 67 ± 10 years, n = 32 female; n = 34 paroxysmal AF) who received radiofrequency redo-procedure due to recurrence of ATA within 6 months after CB-based PVI were included. A point-by point 3D-map was performed, and low-voltage sites were delineated based on bipolar voltage < 0.5 mV. The extent of fibrosis was categorized as stage A (0-10% of the LA wall), stage B (10-30%), stage C (30-50%), and stage D (> 50%).The median area of LA low-voltage sites was 28.9 (9; 50.3) cm2, corresponding to 17.4 (6; 30.6) % of the LA wall surface. 17/60 (28.3%) patients were categorized as fibrosis stage A, 21/60 (35%) as stage B, 18/60 (30%) as stage C, and 4/60 (6.7%) as stage D. Patient age and LA diameter were associated with more pronounced LA fibrosis; the extent of LA fibrosis was significantly higher in patients with LA tachycardia (LAT) during redo-procedures (P < 0.01), and ablation of linear lesions was more often performed (P < 0.01).In patients after CB2-based PVI, expanded LA tissue fibrosis was associated with the occurrence of LAT and more extensive LA ablation during redo-procedures.
AB - Left atrial (LA) fibrosis is associated with a poor outcome after atrial fibrillation (AF) ablation. This study examined the extent of low-voltage areas in patients with recurrence of atrial tachyarrhythmia (ATA) after CB-based pulmonary vein isolation (PVI).Sixty patients (mean age 67 ± 10 years, n = 32 female; n = 34 paroxysmal AF) who received radiofrequency redo-procedure due to recurrence of ATA within 6 months after CB-based PVI were included. A point-by point 3D-map was performed, and low-voltage sites were delineated based on bipolar voltage < 0.5 mV. The extent of fibrosis was categorized as stage A (0-10% of the LA wall), stage B (10-30%), stage C (30-50%), and stage D (> 50%).The median area of LA low-voltage sites was 28.9 (9; 50.3) cm2, corresponding to 17.4 (6; 30.6) % of the LA wall surface. 17/60 (28.3%) patients were categorized as fibrosis stage A, 21/60 (35%) as stage B, 18/60 (30%) as stage C, and 4/60 (6.7%) as stage D. Patient age and LA diameter were associated with more pronounced LA fibrosis; the extent of LA fibrosis was significantly higher in patients with LA tachycardia (LAT) during redo-procedures (P < 0.01), and ablation of linear lesions was more often performed (P < 0.01).In patients after CB2-based PVI, expanded LA tissue fibrosis was associated with the occurrence of LAT and more extensive LA ablation during redo-procedures.
KW - Aged
KW - Atrial Fibrillation/physiopathology
KW - Catheter Ablation/adverse effects
KW - Cryosurgery/adverse effects
KW - Female
KW - Fibrosis/classification
KW - Heart Atria/pathology
KW - Humans
KW - Male
KW - Middle Aged
KW - Pulmonary Veins/surgery
KW - Recurrence
KW - Retrospective Studies
KW - Tachycardia, Supraventricular/epidemiology
KW - Treatment Outcome
U2 - 10.1536/ihj.20-301
DO - 10.1536/ihj.20-301
M3 - SCORING: Journal article
C2 - 33455982
VL - 62
SP - 65
EP - 71
JO - INT HEART J
JF - INT HEART J
SN - 1349-2365
IS - 1
ER -